Literature DB >> 22891111

Allograft coronary artery thrombosis: a case report of early cardiac allograft left ventricular myocardial infarction.

Sergio A Torres1, Omar Cheema, Dipan J Shah, Guillermo Torre-Amione, Jerry D Estep.   

Abstract

Cardiac allograft dysfunction is a major cause of morbidity and mortality in the early post-transplantation period. This is a critical condition that requires prompt diagnosis and management. We present the case of a 57-year-old man with ischemic cardiomyopathy who underwent cardiac transplantation and developed a rare case of coronary artery thrombosis in the setting of heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) within the first 2 postoperative weeks. Transmural myocardial infarction (MI) was initially noted on cardiac magnetic resonance (CMR) imaging as regional left ventricular wall motion abnormalities and transmural hyperenhancement after gadolinium administration, prompting further evaluation of the coronary circulation with angiography.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891111      PMCID: PMC3405789          DOI: 10.14797/mdcj-8-1-46

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  18 in total

1.  A comparison of myocardial perfusion and rejection in cardiac transplant patients.

Authors:  Andrew L Rivard; Cory M Swingen; Donnevan Blake; Andrea S Huang; Pooja Kanth; Grete F Thomsen; Erin J Cordova; Leslie W Miller; Richard W Bianco; Norbert Wilke
Journal:  Int J Cardiovasc Imaging       Date:  2007-01-06       Impact factor: 2.357

2.  Case records of the Massachusetts General Hospital. Case 37-2007. A 47-year-old man with left ventricular dysfunction after heart transplantation.

Authors:  Marc J Semigran; Lynne Warner Stevenson; Jonathan J Passeri; James R Stone
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

3.  Left anterior descending coronary artery bridge. A cause of early death after cardiac transplantation.

Authors:  J Pittaluga; E de Marchena; J D Posada; R Romanelli; A Morales
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

Review 4.  Heparin-induced thrombocytopenia: a historical perspective.

Authors:  John G Kelton; Theodore E Warkentin
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

Review 5.  The role of multimodality cardiac imaging in the transplanted heart.

Authors:  Jerry D Estep; Dipan J Shah; Sherif F Nagueh; John J Mahmarian; Guillermo Torre-Amione; William A Zoghbi
Journal:  JACC Cardiovasc Imaging       Date:  2009-09

6.  Immediate causes of death in short-term surviving heart transplant recipients.

Authors:  P Gallo; L Agozzino; E Arbustini; G Bartoloni; G Baroldi; E Bonacina; C Bosman; G Catani; C di Gioia; T Motta; A Pucci; M Rocco; G Thiene
Journal:  Cardiovasc Pathol       Date:  1994 Jul-Sep       Impact factor: 2.185

7.  Frequency and characteristics of coronary thrombosis in the epicardial coronary arteries after cardiac transplantation.

Authors:  E Arbustini; B Dal Bello; P Morbini; M Grasso; M Diegoli; R Fasani; A Pilotto; O Bellini; C Pellegrini; L Martinelli; C Campagna; A Gavazzi; G Specchia; M Viganò; W C Roberts
Journal:  Am J Cardiol       Date:  1996-10-01       Impact factor: 2.778

Review 8.  Chemokines and transplant vasculopathy.

Authors:  John A Belperio; Abbas Ardehali
Journal:  Circ Res       Date:  2008-08-29       Impact factor: 17.367

9.  Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance.

Authors:  Yijen L Wu; Qing Ye; Kazuya Sato; Lesley M Foley; T Kevin Hitchens; Chien Ho
Journal:  JACC Cardiovasc Imaging       Date:  2009-06

10.  Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction.

Authors:  Sven Plein; John F Younger; Patrick Sparrow; John P Ridgway; Stephen G Ball; John P Greenwood
Journal:  J Cardiovasc Magn Reson       Date:  2008-10-25       Impact factor: 5.364

View more
  1 in total

1.  Complement C5 Inhibition Reduces T Cell-Mediated Allograft Vasculopathy Caused by Both Alloantibody and Ischemia Reperfusion Injury in Humanized Mice.

Authors:  L Qin; G Li; N Kirkiles-Smith; P Clark; C Fang; Y Wang; Z-X Yu; D Devore; G Tellides; J S Pober; D Jane-Wit
Journal:  Am J Transplant       Date:  2016-06-14       Impact factor: 8.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.